Updates are available Correction dated 2024-07-09
Click to view Correction: https://doi.org/10.1038/s41533-024-00376-9
-
Authors
Crooks, M. G.
Cummings, H.
Morice, A. H. http://orcid.org/0000-0002-6135-9610
Sykes, D.
Brooks, S.
Jackson, A.
Xu, Y.
-
Funding
Funding for this research was provided by:
AstraZeneca (N/A, N/A)
- License Information
-
More Information
Article History
Received: 9 October 2023
Accepted: 10 April 2024
First Online: 29 April 2024
Change Date: 9 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41533-024-00376-9
Competing interests
: Michael G Crooks has received grants from the National Institute for Health and Care Research, AstraZeneca, Boehringer Ingelheim, Chiesi, Phillips, and Pfizer; honoraria and/or non-financial support from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis and Pfizer. Helena Cummings has received honoraria from AstraZeneca, Chiesi, Sandoz, and Pfizer. Alyn H Morice received grants from AstraZeneca, Boehringer Ingelheim, Chiesi, MSD and Bayer; honoraria and/or non-financial support from AstraZeneca, Boehringer Ingelheim, Chiesi and MSD. Dominic Sykes has nothing to disclose. Samantha Brooks, Arthur Jackson and Yang Xu are employees of AstraZeneca. Arthur Jackson and Yang Xu own stock in AstraZeneca.
